Drug intelligence / Profile preview

pcDNA-NCF2

Development stage
Preclinical
Lead developer
Shaanxi Provincial People's Hospital
Modality
Gene Therapies
Administration
Intravenous
01

Overview

pcDNA-NCF2 is a recombinant DNA expression plasmid designed to overexpress the Neutrophil Cytoplasmic Factor 2 (NCF2) protein in mammalian cells. NCF2, also known as p67-phox, is a critical cytosolic subunit of the NADPH oxidase complex, which is responsible for the generation of reactive oxygen species (ROS). In the context of cardiovascular research, pcDNA-NCF2 is utilized as a molecular tool to investigate the pathological role of NCF2 upregulation in endothelial dysfunction. Studies have demonstrated that overexpression of NCF2 via this plasmid inhibits the PI3K/Akt/Nrf2 signaling pathway, thereby promoting ferroptosis and inflammatory responses in human umbilical vein endothelial cells (HUVECs). It is primarily used in preclinical research to model the progression of atherosclerosis and to validate the mechanism of action of potential therapeutic agents that target the NCF2-mediated oxidative stress pathway.

Other names
NCF2 expression plasmidNCF-2 expression plasmidNCF 2 expression plasmidpcDNA3.1-NCF2pcDNA-3.1-NCF2pcDNA 3.1-NCF2
02

Targets

RAC2 (Ras-related C3 botulinum toxin substrate 2)NCF1 (Neutrophil cytosolic factor 1)p40phox (Neutrophil cytosol factor 4)NCF2 (Neutrophil cytosolic factor 2)TLR9 (Toll-like receptor 9)Cytochrome b558 (gp91phox-p22phox complex)

Beyond the preview

Go deeper on pcDNA-NCF2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pcDNA-NCF2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call